At a glance
ClinicalIndex Comparison RecordN/ACompleted· 84 enrolled
Drug / intervention
BIOZEK COVID-19 Antigen Rapid Testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test as Compared to Standard Testing Technique. Test Performed by a Professional Versus Self-collection and Standard of Care
In Brief
A clinical study evaluating BIOZEK COVID-19 Antigen Rapid Test for Covid19. Completed, enrolled 84 participants across 1 site.
Detailed Summary
This is a research study to evaluate the Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on samples collected by a healthcare professional versus self-collection; and to perform analysis to compare results. In addition, to obtain RT-PCR test results, performed prior to enrollment, and compare all three results.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartMar 2021
First PostedMar 2021
Primary CompletionFeb 2022
TodayJul 2026
First PostedMar 18, 2021
Enrollment StartMar 17, 2021
Primary CompletionFeb 23, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.3 years ago
Interventions
BIOZEK COVID-19 Antigen Rapid Testother
The BIOZEK COVID-19 Antigen Rapid Test is used for the detection of SARS-CoV-2 antigens in nasopharyngeal swab specimens from individuals who are suspected of having COVID-19.